Format

Send to

Choose Destination
Fertil Steril. 2014 May;101(5):1375-82. doi: 10.1016/j.fertnstert.2014.01.051. Epub 2014 Mar 6.

Development and validation of a next-generation sequencing-based protocol for 24-chromosome aneuploidy screening of embryos.

Author information

1
Genoma Molecular Genetics Laboratory, Rome, Italy. Electronic address: fiorentino@laboratoriogenoma.it.
2
Genoma Molecular Genetics Laboratory, Rome, Italy.
3
Bluegnome, Cambridge, United Kingdom.

Abstract

OBJECTIVE:

To validate a next-generation sequencing (NGS)-based method for 24-chromosome aneuploidy screening and to investigate its applicability to preimplantation genetic screening (PGS).

DESIGN:

Retrospective blinded study.

SETTING:

Reference laboratory.

PATIENT(S):

Karyotypically defined chromosomally abnormal single cells and whole-genome amplification (WGA) products, previously analyzed by array comparative genomic hybridization (array-CGH), selected from 68 clinical PGS cycles with embryos biopsied at cleavage stage.

INTERVENTION(S):

None.

MAIN OUTCOME MEASURE(S):

Consistency of NGS-based diagnosis of aneuploidy compared with either conventional karyotyping of single cells or array-CGH diagnoses of single blastomeres.

RESULT(S):

Eighteen single cells and 190 WGA products from single blastomeres, were blindly evaluated with the NGS-based protocol. In total, 4,992 chromosomes were assessed, 402 of which carried a copy number imbalance. NGS specificity for aneuploidy call (consistency of chromosome copy number assignment) was 99.98% (95% confidence interval [CI] 99.88%-100%) with a sensitivity of 100% (95% CI 99.08%-100%). NGS specificity for aneuploid embryo call (24-chromosome diagnosis consistency) was 100% (95% CI 94.59%-100%) with a sensitivity of 100% (95% CI 97.39%-100%).

CONCLUSION(S):

This is the first study reporting extensive preclinical validation and accuracy assessment of NGS-based comprehensive aneuploidy screening on single cells. Given the high level of consistency with an established methodology, such as array-CGH, NGS has demonstrated a robust high-throughput methodology ready for clinical application in reproductive medicine, with potential advantages of reduced costs and enhanced precision.

KEYWORDS:

Comprehensive chromosome screening; array comparative genomic hybridization; embryo aneuploidy; next-generation sequencing; preimplantation genetic screening

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center